Johnson & Johnson

JNJ · NYSE

$259.36+$5.57 (+2.19%)TodayMarket closed · Oct 20, 7:56 PM ET

Prev close $253.79

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Employees: 138,200
Headquarters: New Brunswick, New Jersey
Listed: Sep 25, 1944
Sector: Health Care
Industry: Pharmaceuticals
Website: jnj.com

Leadership

Johnson & Johnson executives
Name	Title	Since	Age
Joaquin Duato	—	2016	62
Joseph Wolk	—	—	58
Kristen Mulholland	—	—	58
Kathryn Wengel	—	—	59
James Swanson	—	—	59
Vanessa Broadhurst	—	—	56
Elizabeth Forminard	—	—	54
Prof. Dr. John Reed	—	—	67
Tim Schmid	—	—	55
Jennifer Taubert	—	—	61
Marillyn Hewson	—	—	71
Daniel Pinto	—	—	62
Mary Beckerle	—	—	70
Jennifer Doudna	—	—	61
Paula Johnson	—	—	65
Hubert Joly	—	—	65
Mark Mcclellan	—	—	61
John Morikis	—	—	61
Mark Weinberger	—	—	63
Nadja West	—	—	64
Eugene Woods	—	—	60
Jessica Moore	—	2024	—

Revenue by product and region

Fiscal year ended Dec 28, 2025: $94.19B total revenue

By region

United States$53.75B57.1%
Non-US$40.44B42.9%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Johnson & Johnson suppliers and customers
Company	Relationship	Country	Correlation
Bristol-Myers Squibb BMY	Supplier and customer	US	0.83
Pacira BioSciences, Inc. PCRX	Customer	US	0.67
NSI NSI.AS	Supplier	NL	0.67
Amgen AMGN	Supplier and customer	US	0.66
Sanofi SAN.PA	Supplier	FR	0.66
Silgan Holdings Inc. SLGN	Supplier	US	0.64
Bayer BAYN.DE	Supplier and customer	DE	0.64
AbbVie ABBV	Supplier and customer	US	0.63
Berkshire Hathaway B BRK.B	Supplier and customer	US	0.63
McKesson Corporation MCK	Customer	US	0.58

Similar companies

Companies in the same industry as Johnson & Johnson

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.